— Know what they know.
Not Investment Advice

600161.SS SHH

Beijing Tiantan Biological Products Co., Ltd.
1W: +1.9% 1M: +2.9% 3M: +4.7% YTD: -23.7% 1Y: -37.9% 3Y: -38.6% 5Y: -43.0%
¥12.59 ($1.88)
+0.47 (+3.88%)
 
SHH · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · ¥24.9B mcap · 1.98B float · 0.706% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥24.9B ($3.7B)
52W Range11.12-19.38
Volume21,523,527
Avg Volume13,952,280
Beta0.18
Dividend¥0.20
Analyst Ratings
No analyst coverage
Company Info
CEOHui Chuan Yang
Employees5,205
SectorHealthcare
IndustryBiotechnology
IPO Date1998-06-16
No.B2 Shuangqiao Road
Beijing, BE 100024
CN
86 10 6543 4018
About Beijing Tiantan Biological Products Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms